2Duraisamy Senthil, Goutam Ghosh Choudhury, Colby Mclaurin, et al. Vascular endothelial growth factor induces protein synthesis in renal epithelial cells: a potential role in diabetic ncphropathy. Kidney INT 2003;64(2) ,468 -479
3Karen S. Endostatin Heller, Moritz A. Konerding et al. Angiogenesis Inhibitors Endostatin or TNP -470 Reduce Indmal Neovascularizafion and plaque Growth in Apolipoprotetin E -Deficient mice. Basic Science Reports 1999; 6(4) :1726 - 1731
4Doi K, Noiri E, Fujita T. Role of vascular endothelial growth factor in kidney disease. Curr vasc pharmacol. 2010 , 1 [Epub ahead of print] .
5Perletti G, Concari P, Giardini R, et al. Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors. Cancer research, 2000, 60: 1793-1796.
6Flyvbjerg A. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabeto- logia. 2000,43 : 1205-1223.
7Senthil D, Choudhury G, McLaurin C, et al. Vascular endo- thelial growth factor induces protein synthesis in renal epithelial cells: a potential role in diabetic nephropathy. Kidney Int. 2003 , 64: 468-479.
8Moulton K, Heller E, Konerding M, et al. Angiogenesis in- hibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation. 1999,99: 1726-1732.
9Yamamoto Y, Maeshima Y, Kitayama H, et al. Tumstatin peptide,an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes, 2004, 53(7) : 1831 - 1840.
10Perletti G, Concari P, Giardini R, et al. Antitumor activity of endostatin against carcinogen- induced rat primary mammary tumors. Cancer research,2000,60(7) - 1793 - 1796.
